期刊文献+

非小细胞肺癌中凋亡相关蛋白与伴神经内分泌分化表达的相关性

Relationship between expression of apoptosis-associated proteins and neuroendocrine differentiation in non-small cell lung carcinoma
下载PDF
导出
摘要 目的检测非小细胞肺癌(non-small cell lung carcinoma,NSCLC)中凋亡相关蛋白与神经内分泌(neuroendocrine,NE)分化的表达,探讨其相关性。方法采用免疫组织化学染色方法,检测NSCLC组织中survivin,bcl-2蛋白与NSE、Syn及CgA等蛋白的表达,并进行相关性作统计学分析。结果113例NSCLC中,survivin、bcl-2阳性表达率分别为88.5%、58.4%;NSE、Syn和CgA蛋白阳性表达率分别为53.6%、6.2%和26.5%。伴NE分化者占21.2%,其survivin蛋白表达明显高于不伴NE分化组,差异有统计学意义。结论survivin、bcl-2蛋白表达上调可能在NSCLC发生发展中起重要作用。伴NE分化的NSCLC与表达阴性者相比,以survivin为代表的抗凋亡能力明显增强。 Purpose To evaluate the espression of neuroendocrine ( NE ) lung carcinoma (NSCLC) and to explore their relationship. Methods markers and some apoptosis-associated proteins in non-small cell 113 cases of NSCLC were reviewed for subclassification. The immunohistochemical (IHC) methods were used to detect the expression of survivin, bcl-2, NSE, Syn and CgA. The results were analyzed with statistical methods. Results 100 tumours (88. 5% ) showed immunoreactivity for survivin and 66 (58.4%) for bcl-2. 61 (53.6%) cases revealed IHC reactivity for NSE, 7 (6. 2% ) for Syn and 30 (26. 5% ) for CgA. Positivity for either NE marker was identified in 24 (21.2%) samples. In those NSCLC with NE differentiation, there was remarkable higher expression of survivin protein. Conclusions Survivin and bcl-2 protein are important factors correlated with the pathogenesis and development of NSCLC. NSCLC with NE differentiation has obviously higher anti-apoptosis effects as represented by survivin protein.
出处 《临床与实验病理学杂志》 CAS CSCD 北大核心 2008年第3期273-275,共3页 Chinese Journal of Clinical and Experimental Pathology
基金 湖北省自然科学基金(2002AB145) 湖北省科技攻关计划项目(2002AA304B13)
关键词 非小细胞肺癌 凋亡蛋白 神经内分泌分化 免疫组织化学 non-small cell lung carcinoma apoptosis-associated protein neuroendocrine differentiation immunohistochemistry
  • 相关文献

参考文献9

  • 1Kamiya N,Akakura K,Suzuki H,et al. Pretreatment serum level of neuron specific enolase (NSE) as a Prognostic factor in metastatic prostate cancer patients treated with endocrine therapy [ J ]. Eur Uro,2003,44(3) :309 -314.
  • 2Xing N ,Qian J, Bostwick D,et al. Neuroendocrine cells in human prostate over-expression the anti-apoptosis protein survivin [ J ]. Prostate,2001, 48( 1 ) :7 - 15.
  • 3Ekedahl J,Joseph B, Grigoriev M Y, et al. Expression of inhibitor of apoptosis proteins in small and non-small-cell lung careinoma cells[ J ]. Exp Cell Res,2002,279 ( 2 ) :277 - 290.
  • 4Zhang L,Shimizu S,Tsujimoto Y. Two distinct Fas-activated signaling pathways revealed by an antitumor drug D609[ J]. Oncogene, 2005, 24 ( 18 ) : 2954 - 2962.
  • 5Chu J S, Shew J Y, Huang C S. Immunohistochemical analysis of survivin expression in primary breast cancers [ J ]. J Formos Med Assoc,2004,103 ( 12 ) :925 - 931.
  • 6Berrieman H K,Smith L,oKane S L,et al. The expression of bcl-2 family proteins differs between non-small cell lung carcinoma subtypes[ J ]. Cancer, 2005, 103 (7) : 1415 - 1419.
  • 7Kawamukai K, Cesario A, Margaritora S, et al. Tnm independent prognostic factors in lung cancer [ J ]. Rays, 2004,29 (4) : 373 - 376.
  • 8Howe M C ,Chapman A, Kerr K,et al. Neuroendocrine differentiation in non-small cell lung cancer and its relation to prognosis and therapy [ J]. Histopathology ,2005,46 ( 2 ) : 195 - 201.
  • 9Sorhaug S, Steinshamn S, Haaverstad R,et al. Expression of neuroendo-crine markers in non-small cell lung cancer [ J ]. APMIS, 2007,115(2) :152 - 163.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部